Growth Factors of Animal Health Market
The Animal Health Market size was valued at USD 41.50 billion in 2023, and the market is now projected tgrow t97.54 USD billion by 2032, exhibiting a CAGR of 6.3% during the forecast period of 2023-2030.
The pandemic has been anticipated tbe a bane for the entire industrial developments of various market and fields. This has affected the overall supply and demand chains of the particular market. As a result of the government's lockdown and other steps tstop the coronavirus from spreading, all supply activities were postponed, which decreased the amount of product related tthis domain. These factors affected the Animal Health Market growth.
This is the major factor attributing the growth of this particular market. This factor is majorly involved in taking the revenue numbers above the skies and soaring greater heights and alsthe sales and demands have been proliferation and increased its value tgreater extent. The market for veterinary healthcare is anticipated tbe driven by an increase in the prevalence of zoonotic illnesses. An increasing number of people are adopting pets for company, which is leading tan increase in disease contact and the global spread of animal-borne illnesses. The demand for animal care products is expected tbe driven during the forecast period by an increase in awareness of preventive measures and the expanding availability of treatment options. The Centers for Disease Control (CDC) reports that diseases spread by animals infect thousands of Americans annually. These particular growth driving factors have been recorded tattribute the Animal Health Market Share.
It is necessary for a product market twalk with the trends in order tincreases its lucracy and profits in shares and all over revenue. Pet adoption is a big trend in the industry. Pets are typically adopted by people for company, and the trend from pet owners tpet parentages has drastically changed. The veterinary health market is therefore expanding due tthe rise in pet owners. The demand for animal care goods is growing as a result of public-private collaborations because of greater product availability and awareness. This is most likely the result of reorganizing dynamic and sustainable systems that support human residents' health and well-being.
Comprehensive Analysis of Animal Health Market
The segmentation of this particular market has been divided and then further subdivided intvarious categories. The market segments are based on product and include feed, diagnostics, medications, and vaccines. The pharmaceuticals section held the biggest market share among the services. Companion animals and farm animals make up the market segments by animal. The market share for veterinary healthcare was highest among the companion animals segment. Veterinary clinics and hospitals, animal care and rehabilitation facilities, diagnostic centers, and other establishments are among the end-user-based categories of the global animal health market.
North America holds the largest market over the forecast period, according tthe conclusions based on our research methodology. According tthe findings of our research methodology, North America will have the biggest market share in the global animal health industry throughout the course of the projection period. North America exhibits signs of dominant geography due tits technologically superior research and development of diagnostics and treatments. Moreover, zoonotic disease outbreaks and the notable growth in pet adoption are pervasive throughout the area. The region is expected tmaintain a significant proportion during the projected period.
Global markets are fiercely competitive and highly fragmented. Due ttheir creative packaging solutions, a few group of large market companies hold a fair amount of market share. Some of the major Companies includes Zoetis (U.S.), Intervet International B.V. (Netherlands), Elanc(U.S.), Ceva (France), and Virbac (France).
In January 2021, This particular company has attributed the market growth in terms of revenue and shares system. In order tstrengthen their partnership in animal health, INRAE and CEVA SANTE ANIMALE (CEVA) announced an agreement. Testing of vaccinations and anti-infective medications, laboratory personnel exchanges, and several cooperative research projects were all part of this agreement, which was expected tbe finished in 2021.
Segmentation Table
ATTRIBUTE DETAILS
Study Period - 2015-2026
Base Year - 2018
Forecast Period - 2019-2026
Historical Period - 2015-2017
Unit - Value (USD Billion)
Segmentation By Product
- Drugs
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Others
- Vaccines
- Feed
- Diagnostics
- Instruments
- Reagents & Consumables
- Livestock Animals
- Companion Animals
- Veterinary Hospitals & Clinics
- Animal Care & Rehabilitation Centers
- Diagnostic Centers
- Others
- North America (the U.S. and Canada)
- Europe (UK, Germany, France, Scandinavia and the Rest of Europe)
- Asia Pacific (Japan, China, India, Southeast Asia and the Rest of Asia Pacific)
- Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)
- Latin America (Brazil, Mexicand the Rest of Latin America)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Recent Industry Developments Such as Mergers & Acquisitions
- 4.2. Prevalence of Key Veterinary Diseases, in Major Countries
- 4.3. Pet Ownership Statistics, in Key Countries
- 4.4. Overview of Pet Insurance, in Key Countries
- 4.5. Technological Advancements in Veterinary Care products
- 4.6. Key Industry Trends
- 5. Global Animal Health Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Drugs
- 5.2.1.1. Anti-Infectives
- 5.2.1.2. Anti-Inflammatory
- 5.2.1.3. Parasiticides
- 5.2.1.4. Others
- 5.2.2. Vaccines
- 5.2.3. Feed
- 5.2.4. Diagnostics
- 5.2.4.1. Instruments
- 5.2.4.2. Reagents & Consumables
- 5.3. Market Analysis, Insights and Forecast – By Animal
- 5.3.1. Livestock Animals
- 5.3.2. Companion Animals
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Veterinary Hospitals & Clinics
- 5.4.2. Animal Care & Rehabilitation Centers
- 5.4.3. Diagnostic Centers
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Animal Health Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Product
- 6.2.1. Drugs
- 6.2.1.1. Anti-Infectives
- 6.2.1.2. Anti-Inflammatory
- 6.2.1.3. Parasiticides
- 6.2.1.4. Others
- 6.2.2. Vaccines
- 6.2.3. Feed
- 6.2.4. Diagnostics
- 6.2.4.1. Instruments
- 6.2.4.2. Reagents & Consumables
- 6.3. Market Analysis – By Animal
- 6.3.1. Livestock Animals
- 6.3.2. Companion Animals
- 6.4. Market Analysis – By End User
- 6.4.1. Veterinary Hospitals & Clinics
- 6.4.2. Animal Care & Rehabilitation Centers
- 6.4.3. Diagnostic Centers
- 6.4.4. Others
- 6.5. Market Analysis – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Animal Health Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Product
- 7.2.1. Drugs
- 7.2.1.1. Anti-Infectives
- 7.2.1.2. Anti-Inflammatory
- 7.2.1.3. Parasiticides
- 7.2.1.4. Others
- 7.2.2. Vaccines
- 7.2.3. Feed
- 7.2.4. Diagnostics
- 7.2.4.1. Instruments
- 7.2.4.2. Reagents & Consumables
- 7.3. Market Analysis – By Animal
- 7.3.1. Livestock Animals
- 7.3.2. Companion Animals
- 7.4. Market Analysis – By End User
- 7.4.1. Veterinary Hospitals & Clinics
- 7.4.2. Animal Care & Rehabilitation Centers
- 7.4.3. Diagnostic Centers
- 7.4.4. Others
- 7.5. Market Analysis – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Animal Health Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Product
- 8.2.1. Drugs
- 8.2.1.1. Anti-Infectives
- 8.2.1.2. Anti-Inflammatory
- 8.2.1.3. Parasiticides
- 8.2.1.4. Others
- 8.2.2. Vaccines
- 8.2.3. Feed
- 8.2.4. Diagnostics
- 8.2.4.1. Instruments
- 8.2.4.2. Reagents & Consumables
- 8.3. Market Analysis – By Animal
- 8.3.1. Livestock Animals
- 8.3.2. Companion Animals
- 8.4. Market Analysis – By End User
- 8.4.1. Veterinary Hospitals & Clinics
- 8.4.2. Animal Care & Rehabilitation Centers
- 8.4.3. Diagnostic Centers
- 8.4.4. Others
- 8.5. Market Analysis – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Animal Health Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Product
- 9.2.1. Drugs
- 9.2.1.1. Anti-Infectives
- 9.2.1.2. Anti-Inflammatory
- 9.2.1.3. Parasiticides
- 9.2.1.4. Others
- 9.2.2. Vaccines
- 9.2.3. Feed
- 9.2.4. Diagnostics
- 9.2.4.1. Instruments
- 9.2.4.2. Reagents & Consumables
- 9.3. Market Analysis – By Animal
- 9.3.1. Livestock Animals
- 9.3.2. Companion Animals
- 9.4. Market Analysis – By End User
- 9.4.1. Veterinary Hospitals & Clinics
- 9.4.2. Animal Care & Rehabilitation Centers
- 9.4.3. Diagnostic Centers
- 9.4.4. Others
- 9.5. Market Analysis – By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Animal Health Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Product
- 10.2.1. Drugs
- 10.2.1.1. Anti-Infectives
- 10.2.1.2. Anti-Inflammatory
- 10.2.1.3. Parasiticides
- 10.2.1.4. Others
- 10.2.2. Vaccines
- 10.2.3. Feed
- 10.2.4. Diagnostics
- 10.2.4.1. Instruments
- 10.2.4.2. Reagents & Consumables
- 10.3. Market Analysis – By Animal
- 10.3.1. Livestock Animals
- 10.3.2. Companion Animals
- 10.4. Market Analysis – By End User
- 10.4.1. Veterinary Hospitals & Clinics
- 10.4.2. Animal Care & Rehabilitation Centers
- 10.4.3. Diagnostic Centers
- 10.4.4. Others
- 10.5. Market Analysis – By Country/Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. Zoetis
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. Intervet Inc.
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. Elanco
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. Ceva
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. Virbac
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Merck & Co., Inc.
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Novartis AG
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Emergent BioSolutions, Inc.
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. Bayer AG
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 11.5.10. Boehringer Ingelheim International GmbH
- 11.5.10.1. Overview,
- 11.5.10.2. Products & services,
- 11.5.10.3. SWOT analysis,
- 11.5.10.4. Recent developments,
- 11.5.10.5. strategies,
- 11.5.10.6. financials (based on availability)
- 11.5.11. Other Prominent Players
- 11.5.11.1. Overview,
- 11.5.11.2. Products & services,
- 11.5.11.3. SWOT analysis,
- 11.5.11.4. Recent developments,
- 11.5.11.5. strategies,
- 11.5.11.6. financials (based on availability)
- 12. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook